Correlation Between Organoclick and Kancera AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Organoclick and Kancera AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Organoclick and Kancera AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Organoclick AB and Kancera AB, you can compare the effects of market volatilities on Organoclick and Kancera AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Organoclick with a short position of Kancera AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Organoclick and Kancera AB.

Diversification Opportunities for Organoclick and Kancera AB

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between Organoclick and Kancera is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Organoclick AB and Kancera AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kancera AB and Organoclick is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Organoclick AB are associated (or correlated) with Kancera AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kancera AB has no effect on the direction of Organoclick i.e., Organoclick and Kancera AB go up and down completely randomly.

Pair Corralation between Organoclick and Kancera AB

Assuming the 90 days trading horizon Organoclick AB is expected to generate 0.31 times more return on investment than Kancera AB. However, Organoclick AB is 3.24 times less risky than Kancera AB. It trades about -0.06 of its potential returns per unit of risk. Kancera AB is currently generating about -0.04 per unit of risk. If you would invest  308.00  in Organoclick AB on September 13, 2024 and sell it today you would lose (35.00) from holding Organoclick AB or give up 11.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy98.46%
ValuesDaily Returns

Organoclick AB  vs.  Kancera AB

 Performance 
       Timeline  
Organoclick AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Organoclick AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Kancera AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kancera AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Organoclick and Kancera AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Organoclick and Kancera AB

The main advantage of trading using opposite Organoclick and Kancera AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Organoclick position performs unexpectedly, Kancera AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kancera AB will offset losses from the drop in Kancera AB's long position.
The idea behind Organoclick AB and Kancera AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.